HCV RNA PCR
Abbreviation
HCVPCR
Transport Temp
2-8 C (ice packs) or frozen
Stability
Store at 2-8 C up to 3 days, frozen at -20C to -80C up to 6 weeks
Minimum Vol
1 mL
Alternative Specimens
Serum
Reference Ranges
Target Not Detected (TND)=report as “HCV not detected”.
1.00E+08 IU/mL =report as “HCV detected, greater than 1.00E+08 IU/mL”.
Collection Instructions
Routine venipuncture
Transport Container
2 mL screw-cap tube
Methodology
In vitro nucleic acid amplification test for both the detection and quantitation of hepatitis C (HCV) RNA genotypes 1 to 6 in human EDTA plasma or serum.
Clinical Significance
Intended for use as an aid in the diagnosis of HCV infection in the following populations: individuals with evidence of HCV infection with evidence of liver disease, individuals suspected to be actively infected with HCV antibody evidence, and individuals at risk for HCV infection with antibodies to HCV. Detection of HCV RNA indicates the virus is replicating and is evidence of active infection. Used as an aid in the management of HCV-infected patients undergoing anti-viral therapy in conjunction with clinical and laboratory markers of infection. Used to measure baseline, during treatment, at the end of treatment, and at the end of follow-up treatement to determine sustained or non-sustained viral response.
Alternative Names
HCV PCR HCR NAT HCV NAT PCR
Preferred Specimen
Plasma EDTA